NCT05441475 2026-02-25
A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients
Abbisko Therapeutics Co, Ltd
Phase 2 Enrolling by invitation
Clinical Trials
7 trialsNCT06061328 2026-02-04
OASIS
VA Office of Research and Development
Phase NA Enrolling by invitation
NCT02081755 2026-01-27
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Baylor Research Institute
Phase 4 Enrolling by invitation
NCT06882876 2025-09-19
JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study
Xiangya Hospital of Central South University
Phase 1 Enrolling by invitation
NCT04246970 2025-09-15
PreLiveR-T
Hospital Universitario La Fe
Phase NA Enrolling by invitation
NCT07046832 2025-07-02
Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy
MediView XR, Inc.
Phase NA Enrolling by invitation
NCT05171335 2022-09-21
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
The Methodist Hospital Research Institute
Phase 2 Enrolling by invitation